7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
CAS: 284028-90-6
Rif. 3D-JLA02890
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- 2-Methyl-1,5,7,8-tetrahydro-thiopyrano[4,3-d]pyrimidin-4-one
- 2-Methyl-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one
- 2-Methyl-1H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one
- 2-Methyl-3,5,7,8-Tetrahydrothiopyrano(4,3-D)Pyrimidine-4-One
- 2-Methyl-3H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one
- 2-Methyl-5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-ol
- 2-Methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-ol
- 3,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimidin-4-one
- 4H-Thiopyrano[4,3-d]pyrimidin-4-one, 1,5,7,8-tetrahydro-2-methyl-
- 4H-Thiopyrano[4,3-d]pyrimidin-4-one, 3,5,7,8-tetrahydro-2-methyl-
- Vedi altri sinonimi
- Dr 2313
7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one is a glutamate receptor antagonist that blocks the NMDA (N-methyl D-aspartate) receptor. It has been shown to be clinically effective in the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease. 7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one also inhibits neuronal death in clinical studies. 7,8-Dihydro-2-methyl -1H -thiopyrano[4,3 -d]pyrimidin -4(5H) -one is also used to treat acute stroke patients with locomotor difficulties. The binding site of 7,8--dihydro--2--methyl--1